tiprankstipranks
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
ALGS
Aligos Therapeutics
RESEARCH TOOLSreports
Want to see ALGS full AI Analyst Report?

Aligos Therapeutics (ALGS) Revenue

301 Followers
StatisticsMarket CapRevenue

Aligos Therapeutics Revenue

Aligos Therapeutics had a revenue of 2.83M in the quarter ending Mar 31, 2026, with 1574.56%. This bring the company's revenue in the last twelve months to 4.71M, Decreased 115.23%. In the fiscal year ending Dec 31, 2025, Aligos Therapeutics had annual revenue of 2.19M with -44.59% growth.
Revenue (ttm)
4.71M
Revenue Growth
43.88%
P/S Ratio
18.23
Revenue/Employee
$31,229
Employees
70
Market Cap
$39.85M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
2.19M-1.76M-44.59%
Dec 31, 2024
3.94M-11.58M-74.60%
Dec 31, 2023
15.53M1.62M+11.66%
Dec 31, 2022
13.91M9.55M+219.04%
Dec 31, 2021
4.36M―+∞%
Dec 31, 2020
―――
Dec 31, 2019
―――
Dec 31, 2018
―――